Advanced NeuroPlus
On sale on the US market (according to the DSLD)
Allergy Research Group, food supplement from the US market
Advanced NeuroPlus (Allergy Research Group), a food supplement au code-barres 713947770102, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Allergy Research Group
- Barcode
- 713947770102
- Form
- Tablet
- One serving
- 3 tablets
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Dicalcium Phosphate, Cellulose, Silicon Dioxide, Stearic Acid
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Neumentix | Blend | 900 mg |
| Lion's Mane (Hericium erinaceus) | Plant | 600 mg |
| Acetyl L-Carnitine | Other substance | 500 mg |
| NeuroFactor (Coffea arabica) | Plant | 200 mg |
| American Ginseng Root Extract (Panax quinquefolius) | Plant | 200 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Advanced NeuroPlus
Entered into DSLD on 23 May 2024. Withdrawn from the US market on 5 October 2023 (according to the DSLD).- Active ingredient added : Cognizin (500 mg)
- Active ingredient added : NTFactor Proprietary Lipid Blend (500 mg)
- Active ingredient removed : Acetyl L-Carnitine (500 mg)
Official label: Advanced NeuroPlus
Entered into DSLD on 22 January 2022. On sale on the US market (according to the DSLD).- Active ingredient added : American Ginseng (Panax quinquefolius) (root) extract (200 mg)
- Active ingredient added : Citicoline (500 mg)
- Active ingredient added : Coffea arabica (fruit) extract (200 mg)
- Active ingredient added : NTFactor Proprietary Lipid Blend (500 mg)
- Active ingredient removed : Acetyl L-Carnitine (500 mg)
- Active ingredient removed : American Ginseng Root Extract (200 mg)
- Active ingredient removed : NeuroFactor (200 mg)
- Same quantity, different name: Spearmint (Mentha spicata) (aerial parts) extract in this version; Neumentix on the displayed label (900 mg)
Official label: Advanced NeuroPlus
Entered into DSLD on 23 August 2020. Withdrawn from the US market on 2 August 2021 (according to the DSLD).- Active ingredient added : American Ginseng (Panax quinquefolius) (root) extract (200 mg)
- Active ingredient added : Citicoline (500 mg)
- Active ingredient added : Coffea arabica (fruit) extract (200 mg)
- Active ingredient added : NTFactor Proprietary Lipid Blend (500 mg)
- Active ingredient removed : Acetyl L-Carnitine (500 mg)
- Active ingredient removed : American Ginseng Root Extract (200 mg)
- Active ingredient removed : NeuroFactor (200 mg)
- Same quantity, different name: Spearmint (Mentha spicata) (aerial parts) extract in this version; Neumentix on the displayed label (900 mg)
Official label: Advanced NeuroPlus Brain Nutrition
Entered into DSLD on 23 October 2019. Withdrawn from the US market on 4 August 2020 (according to the DSLD).- Active ingredient added : American Ginseng (Panax quinquefolius) (root) extract (200 mg)
- Active ingredient added : Citicoline (500 mg)
- Active ingredient added : Coffea arabica (fruit) extract (200 mg)
- Active ingredient added : NTFactor Proprietary Lipid Blend (500 mg)
- Active ingredient removed : Acetyl L-Carnitine (500 mg)
- Active ingredient removed : American Ginseng Root Extract (200 mg)
- Active ingredient removed : NeuroFactor (200 mg)
- Same quantity, different name: Spearmint (Mentha spicata) (aerial parts) extract in this version; Neumentix on the displayed label (900 mg)
Official label: Advanced NeuroPlus Brain Nutrition
Entered into DSLD on 21 September 2017. Withdrawn from the US market on 26 June 2019 (according to the DSLD).- Active ingredient added : American Ginseng (Panax quinquefolius) (root) extract (200 mg)
- Active ingredient added : Citicoline (500 mg)
- Active ingredient added : Coffea arabica (fruit) extract (200 mg)
- Active ingredient added : NTFactor Proprietary Lipid Blend (500 mg)
- Active ingredient removed : Acetyl L-Carnitine (500 mg)
- Active ingredient removed : American Ginseng Root Extract (200 mg)
- Active ingredient removed : NeuroFactor (200 mg)
- Same quantity, different name: Spearmint (Mentha spicata) (aerial parts) extract in this version; Neumentix on the displayed label (900 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- NeuroFactor
Read the warning, when it applies and the studies cited
GREEN COFFEE BEAN EXTRACT
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Contraindications
Do not use if you are pregnant.
- American Ginseng Root Extract
Read the warning, when it applies and the studies cited
PANAX QUINQUEFOLIUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or digoxin (Brinker 2010; Dasgupta et al. 2007; Elmer et al. 2007; Yuan et al. 2004).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Dasgupta A, Kang E, Olsen M, Actor JK, Datta P. Interference of Asian, American, and Indian (Ashwagandha) ginseng in serum digoxin measurements by a fluorescence polarization immunoassay can be minimized by using a new enzyme-linked chemiluminescent immunosorbent or turbidimetric assay. Archives of Pathology & Laboratory Medicine 2007;131(4):619-621. PubMed
- Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. The Annals of Pharmacotherapy 2007;41(10):1617-1624. PubMed
- Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J. American ginseng reduces warfarin's effect in healthy patients. Annals of internal medicine 2004;141(1):23-27. PubMed Randomised trial
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Dascalu et al. 2007; Vuksan et al. 2000a,b,c).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Dascalu A, Sievenpiper JL, Jenkins AL, Stavro MP, Leiter LA, Arnason JT, Vuksan V. Five batches representative of Ontario-grown American ginseng root produce comparable reductions of postprandial glycemia in healthy individuals. Canadian Journal of Physiology and Pharmacology 2007;85(9):856-864. PubMed
- Vuksan V, Xu Z, Jenkins AL, Belgan U, Sievenpiper JL, Leiter LA, Josse RG, Stavro MP.American ginseng (Panax quinquefolium L.) improves long-term glycemic control in type 2 diabetes: double-blind placebo controlled crossover trial. Diabetes 2000a;49 (Suppl.1):A95.
Condition of application: All products except Glucose levels and Adaptogen - immune system.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Allergy Research Group
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.